Apellis Pharmaceuticals Presses On With Late-Stage Studies After Trial Enrollment Pause

Apellis Pharmaceuticals Presses On With Late-Stage Studies After Trial Enrollment Pause.....»»

Category: topSource: seekingalphaMar 15th, 2019

AbbVie halts enrollment after brain cancer trial misses goal, shares fall

AbbVie Inc said on Friday it has halted enrollment of patients in all ongoing studies testing its brain cancer treatment after the drug failed to meet the main goal in a late-stage trial......»»

Category: topSource: reutersMay 17th, 2019

BioCryst Trades Sharply Lower Despite Acing Late-Stage Hereditary Angioedema Drug Trial

Shares of BioCryst Pharmaceuticals, Inc. read more.....»»

Category: blogSource: benzingaMay 21st, 2019

Tracon Pharmaceuticals shares slide 45% premarket after it ends trial of cancer treatment

Tracon Pharmaceuticals Inc. shares slid 45% in premarket trade Friday, after the cmpany said it is terminating a late-stage trial of a cancer treatment at the recommendation of an independent committee. The company said its phase 3 tria.....»»

Category: topSource: marketwatchApr 12th, 2019

Biogen Crashes After Abandoning Alzheimer"s Drug Trial

Biogen has lost over a quarter of its market cap in the pre-market after the biotech giant and partner Eisai decided to stop late-stage studies of their Alzheimer’s disease drug.....»»

Category: blogSource: zerohedgeMar 21st, 2019

Is Aquinox Pharmaceuticals Done?

Aquinox Pharmaceuticals saw its shares crash on Wednesday after the firm gave a disappointing update for a late-stage trial......»»

Category: blogSource: 247wallstJun 27th, 2018

Foamix stock surges 30% on positive late-stage results for acne medication

Foamix Pharmaceuticals Ltd. shares surged 30% in Wednesday premarket trade after the company reported positive late-stage trial results for its topical acne medication, FMX101. The phase 3 tria.....»»

Category: topSource: marketwatchSep 12th, 2018

Why Foamix Shares Are Booming

Foamix Pharmaceuticals shares were last seen up early on Wednesday after the company announced a solid performance in its late-stage trial for moderate-to-severe acne......»»

Category: blogSource: 247wallstSep 12th, 2018

Regeneron"s Dupixent Meets Goals in Nasal Polyps Studies

Regeneron's (REGN) atopic dermatitis drug, Dupixent meets goals in two late-stage studies for nasal polyps. Regeneron Pharmaceuticals, Inc. REGN and p.....»»

Category: worldSource: nytOct 17th, 2018

Supernus Gets Crushed Despite Positive ADHD Study Results

Supernus Pharmaceuticals shares dipped on Thursday despite the firm posted positive results from two of its late-stage studies in children for the treatment of attention deficit hyperactivity........»»

Category: blogSource: 247wallstDec 6th, 2018

Intercept Shares Soar To Multimonth High After NASH Drug Aces Late-Stage Trial

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) — which is a frontrunner along with Gilead Sciences, Inc. read more.....»»

Category: blogSource: benzingaFeb 19th, 2019

Pfizer"s Lyrica doesn"t meet endpoint in epilepsy study

Pfizer Inc. said late Friday one of its drugs did not meet set goals for the treatment of epilepsy in a late stage clinical trial. Pfizer said a Phase 3 clinical t.....»»

Category: topSource: marketwatchMay 24th, 2019

Why BioCryst’s HAE Treatment Failed to Impress

BioCryst Pharmaceuticals shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary angioedema patients......»»

Category: blogSource: 247wallstMay 21st, 2019

Bristol-Myers slides after Opdivo fails late-stage brain cancer trial

See the rest of the story here. provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytMay 9th, 2019

Progenics Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update

AZEDRA® (iobenguane I 131) U.S. Commercial Launch Advancing with 22 Treatment Requests from Patients Received and 12 Centers Throughout the U.S. are Ready to Treat Patients Phase 2 Trial of 1095 Initiated with Enrollment to Begin 2Q.....»»

Category: earningsSource: benzingaMay 9th, 2019

Osmotica Pharma Makes Significant Headway With Ptosis Treatment

Osmotica Pharma shares jumped on Tuesday after the firm announced results from its late-stage trial for the treatment of ptosis (droopy eyelid)......»»

Category: blogSource: 247wallstMay 7th, 2019

GW Pharmaceuticals stock rises 6% after positive CBD drug trial

GW Pharmaceuticals PLC said late Monday that it had a positive phase-three trial result for its Epidiolex drug. GW stock rose more than 7% in af.....»»

Category: topSource: marketwatchMay 6th, 2019

Gilead shares slip 0.2% after second NASH trial fails

Shares of Gilead Sciences Inc. slipped 0.2% in premarket trade Thursday after the company said a late-stage study lo.....»»

Category: topSource: marketwatchApr 25th, 2019

Tracon Pharma terminates late-stage trial of cancer treatment

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 12th, 2019

Why Galapagos NV Stock Bolted Higher in March

Galapagos' experimental rheumatoid arthritis drug hit the mark in two late-stage studies last month......»»

Category: topSource: foxnewsApr 9th, 2019

PTSD Treatment Looked at for Fibromyalgia

Tonix Pharmaceuticals shares jumped on Monday after the firm announced the expansion of its late-stage PTSD treatment......»»

Category: blogSource: 247wallstApr 4th, 2019